Alterity Therapeutics (PRNAD) Interest & Investment Income (2018 - 2019)
Alterity Therapeutics (PRNAD) posted quarterly Interest & Investment Income of $9655.5 for Q4 2019, down 79.72% year-over-year from $47609.3 in Q4 2018, and down 79.72% on a QoQ basis from $47609.3 in Q4 2018.
Alterity Therapeutics (PRNAD) Interest & Investment Income (2018 - 2019) Analysis & Trends
Alterity Therapeutics (PRNAD) has reported Interest & Investment Income for 2 consecutive years, with $9655.5 the latest figure, recorded in Q4 2019.
- In Q4 2019, Interest & Investment Income fell 79.72% year-over-year to $9655.5; the TTM figure through Dec 2019 stood at $465970.4 (changed N/A YoY), while the FY2025 annual figure was $285819.6, up 61.58% from the prior year.
- Interest & Investment Income came in at $9655.5 for Q4 2019 at Alterity Therapeutics, down from $47609.3 in the prior quarter.
- The five-year high for Interest & Investment Income was $47609.3 in Q4 2018, with the low at $9655.5 in Q4 2019.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 9,655.51 |
| Dec 31, 2018 | 47,609.30 |